cAMP-stimulated Protein Phosphatase 2A Activity Associated with Muscle A Kinase-anchoring Protein (mAKAP) Signaling Complexes Inhibits the Phosphorylation and Activity of the cAMP-specific Phosphodiesterase PDE4D3
Open accessThe DOI matches its Crossref record.
Abstract
The concentration of the second messenger cAMP is tightly controlled in cells by the activity of phosphodiesterases. We have previously described how the protein kinase A-anchoring protein mAKAP serves as a scaffold for the cAMP-dependent protein kinase PKA and the cAMP-specific phosphodiesterase PDE4D3 in cardiac myocytes. PKA and PDE4D3 constitute a negative feedback loop whereby PKA-catalyzed phosphorylation and activation of PDE4D3 attenuate local cAMP levels. We now show that protein phosphatase 2A (PP2A) associated with mAKAP complexes is responsible for reversing the activation of PDE4D3 by catalyzing the dephosphorylation of PDE4D3 serine residue 54. Mapping studies reveal that a C-terminal mAKAP domain (residues 2085-2319) binds PP2A. Binding to mAKAP is required for PP2A function, such that deletion of the C-terminal domain enhances both base-line and forskolin-stimulated PDE4D3 activity. Interestingly, PP2A holoenzyme associated with mAKAP complexes in the heart contains the PP2A targeting subunit B56delta. Like PDE4D3, B56delta is a PKA substrate, and PKA phosphorylation of mAKAP-bound B56delta enhances phosphatase activity 2-fold in the complex. Accordingly, expression of a B56delta mutant that cannot be phosphorylated by PKA results in increased PDE4D3 phosphorylation. Taken together, our findings demonstrate that PP2A associated with mAKAP complexes promotes PDE4D3 dephosphorylation, serving both to inhibit PDE4D3 in unstimulated cells and also to mediate a cAMP-induced positive feedback loop following adenylyl cyclase activation and B56delta phosphorylation. In general, PKA.PP2A.mAKAP complexes exemplify how protein kinases and phosphatases may participate in molecular signaling complexes to dynamically regulate localized intracellular signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Advances in targeting cyclic nucleotide phosphodiesterases
Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J., & Manganiello, V. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4228 · Cited by 776
PP2A as a master regulator of the cell cycle
Wlodarchak, N., & Xing, Y. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2016.1143913 · Cited by 371
Subcellular Organization of the cAMP Signaling Pathway
Zaccolo, M., Zerio, A., & Lobo, M. J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000086 · Cited by 275
Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets
Ahmad, F., Murata, T., Shimizu, K., Degerman, E., Maurice, D., & Manganiello, V (2015) · Oral Diseases · doi:10.1111/odi.12275 · Cited by 184
“…and diversity of compartmentalized cyclic nucleotide signaling and allows integration and cross talk between cyclic nucleotide signals and other signaling networks and systems (Dodge et al, 2001; Houslay et al, 2007; Dodge-Kafka et al, 2010; Stangherlin et al, 2011; Kritzer et al, 2012).”
BackgroundInfluentialMechanisms of Protein Kinase A Anchoring
(2010) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(10)83005-9 · Cited by 175
Structure, Regulation, and Pharmacological Modulation of PP2A Phosphatases
Lambrecht, C., Haesen, D., Sents, W., Ivanova, E., & Janssens, V. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-562-0_17 · Cited by 140
B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability
Houge, G., Haesen, D., Vissers, L. E. L. M., Mehta, S., Parker, M. J., Wright, M., Vogt, J., McKee, S., Tolmie, J. L., Cordeiro, N., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79860 · Cited by 124
“One example could be the signaling complex scaffolded by the neural variant of the cAMP-dependent PKA anchoring protein mAKAP, that binds B56δ and several other phosphatases (PP1, PP2B) and kinases (PKA, PDK1, RSK3, ERK5) (26, 27).”
BackgroundKirchhefer, U., Brekle, C., Eskandar, J., Isensee, G., Kučerová, D., Müller, F. U., Pinet, F., Schulte, J. S., Seidl, M. D., & Boknik, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.598938 · Cited by 52
“Moreover, PP2A activity itself is regulated by a PKA-dependent phosphorylation of its regulatory B subunits after sympathetic activation, serving as a feedback mechanism on phosphorylated targets (13, 46, 47).”
BackgroundThe adeno-associated virus Rep proteins target PP4:SMEK1 by preventing substrate recruitment
Vandewinkel, B., Torrekens, S., Claes, Z., Bollen, M., & Henckaerts, E. (2026) · PLOS Pathogens · doi:10.1371/journal.ppat.1014025
The adeno-associated virus Rep proteins target PP4:SMEK1 by preventing substrate-recruitment
Vandewinkel, B., Torrekens, S., Claes, Z., Bollen, M., & Henckaerts, E. (2025) · doi:10.1101/2025.06.13.659448
Metadata
- Authors
- Dodge-Kafka, K. L., Bauman, A., Mayer, N., Henson, E., Heredia, L., Ahn, J., McAvoy, T., Nairn, A. C., & Kapiloff, M. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 285
- Issue
- 15
- Pages
- 11078-11086
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2018537340
- Cited by
- 97
- References
- 0
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.